It results in fewer modifications, and less manufacturing and construction.
Thanks to her expertise in healthcare architecture, she has primarily focused on refining the internal layout of the hospital, through the ongoing engagement of stakeholders and user groups from Circle hospitals.. Martina has led the team through the construction stage for Circle Birmingham, with a design, management and coordinating role on the project which involves dealing with clients, contractors and external consultants.She is also involved in the detail design of the hospital’s rehabilitation expansion of the project, overseeing the design process and the interference with the hospital scheme currently on site.. Martina is also involved in Healthcare projects for the MoJ (as part of the current Prisons Estate Transformation Project), and compliance checks for medical facilities in Europe and Asia.Jami leads the ‘Central Logic’ approach at Bryden Wood, and her work sits at the intersection between Architecture,.
Design for Manufacture and Assembly (DfMA).and Digital Innovation.. Jami’s simultaneous involvement with our., Creative Technologies and Integrated Design teams allows her to straddle the virtual and real worlds, and to push the boundaries of traditional architectural design.
She delivers solutions that combine cutting-edge approaches to.with digital technology for both public and private sector clients alike, (particularly within the residential and education sectors.)Bernat joined Bryden Wood in January 2018..
Previously, Bernat was involved in delivering a wide range of structural solutions, from small and medium residential developments to industrial and commercial projects; including new builds, extensions and refurbishment of Grade I and II listed buildings.
Bernat has a strong academic background to support his problem-solving skills, and contributing to the knowledge and capability of the structures team..These innovations promise to deliver lean and agile manufacturing, reducing waste, improving quality, and enabling the production of more complex molecules more efficiently.. 4.
The future of pharmaceutical manufacturing:.A significant focus is on the concept of miniaturisation and continuous processing as part of a new paradigm in drug manufacturing.
This approach not only reduces the environmental footprint and costs but also enhances safety and quality by enabling smaller, more controlled, and flexible production processes.. 5.Barriers and opportunities for change:.